| Old Articles: <Older 12721-12730 Newer> |
 |
Investment Advisor May 1, 2011 Kathleen McBride |
SEC and the Fiduciary Study: Where Do We Go From Here? It's not whether to extend fiduciary duty, but how to extend it  |
Investment Advisor May 1, 2011 Kathleen McBride |
UBS to Pay FINRA Fine and Restitution to Investors in Lehman PPNs Bank BD to pay over $10 million in fines for omissions and misleading investors  |
Investment Advisor May 1, 2011 Thomas D. Giachetti |
You Can't Regulate Crooks Unnecessary regulation annoys the good guys, and doesn't stop the bad guys  |
Investment Advisor May 1, 2011 |
More Than Kin, Less Than Kind Legitimate questions raised by Republicans should be answered. The problem is that the incestuous relationship the SEC has with the industry does not allow a frank discussion of what regulatory reform means to the consumer for fear of criticizing the industry's current state.  |
Investment Advisor May 1, 2011 Bob Clark |
The Polar Bears Thawing out our modern black and white thinking could save the fiduciary standard. I don't usually write about politics, except when it has a direct impact on financial advice, and this appears to be one of those times.  |
Information Today April 25, 2011 Paula J. Hane |
InnoCentive Links Problems and Problem-Solvers In a day and age when `thinking outside the box' is universally touted as the fastest path to scientific and technological innovation, incentive prize contests have come to be seen as one of the most creative ways to generate groundbreaking ideas.  |
Investment Advisor April 25, 2011 James J. Green |
Why the IA 25 Is Important and Instructive "Get used to the government being your partner." For good or ill, that is certainly the case for the foreseeable future  |
The Motley Fool April 25, 2011 Luke Timmerman |
Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week Most analysts see Vertex's drug as best-in-class. But what does the FDA have to say about it?  |
Investment Advisor April 11, 2011 Melanie Waddell |
SEC to Meet Dodd-Frank's July Deadline on 'Switch,' Private Fund, Venture Fund Advisors While final rules will be out by July 21, SEC will give advisors more time to comply  |
The Motley Fool April 23, 2011 |
St. Jude, Medtronic Execs Offer Different Views on JAMA Article's Impact An article and government investigation into implant devices may or may not have played a role in each company's performance, depending on whom you ask.  |
| <Older 12721-12730 Newer> Return to current articles. |